Serum miRNA‑142 and BMP‑2 are markers of recovery following hip replacement surgery for femoral neck fracture

Gao,Haoyuan; Wang,Xuyou

doi:10.3892/etm.2020.9235

Serum miRNA‑142 and BMP‑2 are markers of recovery following hip replacement surgery for femoral neck fracture

Authors:
- Haoyuan Gao
- Xuyou Wang
View Affiliations

Affiliations: Department of Orthopedics, The Fourth Hospital of Jinan, Jinan, Shandong 250021, P.R. China, Department of Laboratory Medicine, Wulian People's Hospital, Shandong 262300, P.R. China
Published online on: September 18, 2020 https://doi.org/10.3892/etm.2020.9235
Article Number: 105
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the changes in miRNA‑142 and bone morphogenetic protein‑2 (BMP‑2) expression before and after hip replacement surgery, and to determine their association with receptor activator of NF‑κB ligand (RANKL) and osteoprotegerin (OPG). For this purpose, 142 cases of hip arthroplasty in patients with femoral neck fracture were selected as the research group, and 50 cases of healthy individuals who underwent a physical examination during the same time period were selected the control group. Serum miR‑142 and BMP‑2 levels were measured by RT‑qPCR before and after surgery in the research group and the control group. Serum RANKL and OPG levels were detected before and after surgery by enzyme‑linked immunosorbent assay (ELISA). The levels of serum miR‑142 and BMP‑2 in the research group were significantly lower than those in the control group. At 1 month after surgery, the levels of serum miR‑142 and BMP‑2 in the research group were significantly higher than those before surgery, and at 6 months after surgery, and they were higher than those in the control group. Pearson's correlation analysis revealed that the serum levels of miR‑142 positively correlated with the BMP‑2 levels before surgery, at 1 month after surgery, and at 6 months after surgery in the research group. The results of ROC curve analysis revealed that the AUC values of serum miR‑142 and BMP‑2 were 0.911 and 0.861, respectively. At 1 month after surgery, the levels of serum miR‑142 and BMP‑2 in group A (patients with a good or excellent recovery) were significantly higher than those in group B (patients with a fair or poor recovery). The levels of serum RANKL and OPG in the research group significantly increased at 1 month after surgery. The serum levels of miR‑142 and BMP‑2 positively correlated with those of RANKL and OPG before surgery and at 1 month after surgery. On the whole, the findings of the present study indicate that pre‑operative serum miR‑142 and BMP‑2 levels are valuable for evaluating the post‑operative recovery of patients with femoral neck fracture undergoing hip replacement surgery. In addition, in the present study, at 1 month after surgery, the levels of both miR‑142 and BMP‑2 were related to the recovery of the patients, and positively correlated with the RANKL and OPG levels.

View Figures

View References

1	Yu L, Wang Y and Chen J: Total hip arthroplasty versus hemiarthroplasty for displaced femoral neck fractures: Meta-analysis of randomized trials. Clin Orthop Relat Res. 470:2235–2243. 2012.PubMed/NCBI View Article : Google Scholar
2	Lowe JA, Crist BD, Bhandari M and Ferguson TA: Optimal treatment of femoral neck fractures according to patient's physiologic age: An evidence-based review. Orthop Clin North Am. 41:157–166. 2010.PubMed/NCBI View Article : Google Scholar
3	Miyamoto RG, Kaplan KM, Levine BR, Egol KA and Zuckerman JD: Surgical management of hip fractures: An evidence-based review of the literature. II: Intertrochanteric fractures. J Am Acad Orthop Surg. 16:596–607. 2008.PubMed/NCBI View Article : Google Scholar
4	Alnahhal A, Aslam-Pervez N and Sheikh HQ: Templating Hip arthroplasty. Open Access Maced J Med Sci. 7(672)2019.PubMed/NCBI View Article : Google Scholar
5	Nemes S, Lind D, Cnudde P, Bülow E, Rolfson O and Rogmark C: Relative survival following hemi-and total hip arthroplasty for hip fractures in Sweden. BMC Musculoskelet Disord. 19(407)2018.PubMed/NCBI View Article : Google Scholar
6	Maratt JD, Gagnier JJ, Butler PD, Hallstrom BR, Urquhart AG and Roberts KC: No difference in dislocation seen in anterior vs posterior approach total hip arthroplasty. J Arthroplasty. 31:127–130. 2016.PubMed/NCBI View Article : Google Scholar
7	Li D, Liu J, Guo B, Liang C, Dang L, Lu C, He X, Cheung HY, Xu L, Lu C, et al: Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat Commun. 7(10872)2016.PubMed/NCBI View Article : Google Scholar
8	Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T and Zhang Y: MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol. 8(212)2012.PubMed/NCBI View Article : Google Scholar
9	Xu R, Bi C, Song J, Wang L, Ge C, Liu X and Zhang M: Upregulation of miR-142-5p in atherosclerotic plaques and regulation of oxidized low-density lipoprotein-induced apoptosis in macrophages. Mol Med Rep. 11:3229–3234. 2015.PubMed/NCBI View Article : Google Scholar
10	Schaefer JS, Montufar-Solis D, Vigneswaran N and Klein JR: Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon. J Immunol. 187:5834–5841. 2011.PubMed/NCBI View Article : Google Scholar
11	Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui J, Liu Y, Gao Z, Li J, Shen L and Lu Y: Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol. 22:2257–2266. 2011.PubMed/NCBI View Article : Google Scholar
12	Wang YK, Yu X, Cohen DM, Wozniak MA, Yang MT, Gao L, Eyckmans J and Chen CS: Bone morphogenetic protein-2-induced signaling and osteogenesis is regulated by cell shape, RhoA/ROCK, and cytoskeletal tension. Stem Cells Dev. 21:1176–1186. 2011.PubMed/NCBI View Article : Google Scholar
13	Chen J, Li K, Pang Q, Yang C, Zhang H, Wu F, Cao H, Liu H, Wan Y, Xia W, et al: Identification of suitable reference gene and biomarkers of serum miRNAs for osteoporosis. Sci Rep. 6(36347)2016.PubMed/NCBI View Article : Google Scholar
14	Mi M, Jin H, Wang B, Yukata K, Sheu TJ, Ke QH, Tong P, Im HJ, Xiao G and Chen D: Chondrocyte BMP2 signaling plays an essential role in bone fracture healing. Gene. 512:211–218. 2013.PubMed/NCBI View Article : Google Scholar
15	Krege JH, Lane NE, Harris JM and Miller PD: PINP as a biological response marker during teriparatide treatment for osteoporosis. Osteoporos Int. 25:2159–2171. 2014.PubMed/NCBI View Article : Google Scholar
16	Martin TJ and Sims NA: RANKL/OPG; Critical role in bone physiology. Rev Endocr Metab Disord. 16:131–139. 2015.PubMed/NCBI View Article : Google Scholar
17	Cassuto J, Folestad A, Göthlin J, Malchau H and Kärrholm J: The key role of proinflammatory cytokines, matrix proteins, RANKL/OPG and Wnt/β-catenin in bone healing of hip arthroplasty patients. Bone. 107:66–77. 2018.PubMed/NCBI View Article : Google Scholar
18	Davenport DL, Bowe EA, Henderson WG, Khuri SF and Mentzer RM Jr: National surgical quality improvement program (NSQIP) risk factors can be used to validate American Society of Anesthesiologists Physical Status Classification (ASA PS) levels. Ann Surg. 243:636–644. 2006.PubMed/NCBI View Article : Google Scholar
19	Wright NC, Saag KG, Dawson-Hughes B, Khosla S and Siris ES: The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA. Osteoporos Int. 28:1225–1232. 2017.PubMed/NCBI View Article : Google Scholar
20	Sprague S, Bhandari M, Heetveld MJ, Liew S, Scott T, Bzovsky S, Heels-Ansdell D, Zhou Q, Swiontkowski M and Schemitsch EH: FAITH Investigators: Factors associated with health-related quality of life, hip function, and health utility after operative management of femoral neck fractures. Bone Joint J. 100-B:361–369. 2018.PubMed/NCBI View Article : Google Scholar
21	Singh JA, Schleck C, Harmsen S and Lewallen D: Clinically important improvement thresholds for Harris Hip Score and its ability to predict revision risk after primary total hip arthroplasty. BMC Musculoskelet Disord. 17(256)2016.PubMed/NCBI View Article : Google Scholar
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
23	Abdel MP, Watts CD, Houdek MT, Lewallen DG and Berry DJ: Epidemiology of periprosthetic fracture of the femur in 32 644 primary total hip arthroplasties: A 40-year experience. Bone Joint J. 98:461–467. 2016.PubMed/NCBI View Article : Google Scholar
24	Mahmood SS, Mukka SS, Crnalic S, Wretenberg P and Sayed-Noor AS: Association between changes in global femoral offset after total hip arthroplasty and function, quality of life, and abductor muscle strength: A prospective cohort study of 222 patients. Acta Orthop. 87:36–41. 2016.PubMed/NCBI View Article : Google Scholar
25	Angerame MR, Fehring TK, Masonis JL, Mason JB, Odum SM and Springer BD: Early failure of primary total hip arthroplasty: Is surgical approach a risk factor? J Arthroplasty. 33:1780–1785. 2018.PubMed/NCBI View Article : Google Scholar
26	Lee WY, Li N, Lin S, Wang B, Lan HY and Li G: miRNA-29b improves bone healing in mouse fracture model. Mol Cell Endocrinol. 430:97–107. 2016.PubMed/NCBI View Article : Google Scholar
27	Waki T, Lee SY, Niikura T, Iwakura T, Dogaki Y, Okumachi E, Oe K, Kuroda R and Kurosaka M: Profiling microRNA expression during fracture healing. BMC Musculoskelet Disord. 17(83)2016.PubMed/NCBI View Article : Google Scholar
28	Liu X and Xu X: MicroRNA-137 dysregulation predisposes to osteoporotic fracture by impeding ALP activity and expression via suppression of leucine-rich repeat-containing G-protein-coupled receptor 4 expression. Int J Mol Med. 42:1026–1033. 2018.PubMed/NCBI View Article : Google Scholar
29	Yao CJ, Lv Y, Zhang CJ, Jin JX, Xu LH, Jiang J, Geng B, Li H, Xia YY and Wu M: MicroRNA-185 inhibits the growth and proliferation of osteoblasts in fracture healing by targeting PTH gene through down-regulating Wnt/β-catenin axis: In an animal experiment. Biochem Biophys Res Commun. 501:55–63. 2018.PubMed/NCBI View Article : Google Scholar
30	Rogers MB, Shah TA and Shaikh NN: Turning bone morphogenetic protein 2 (BMP2) on and off in mesenchymal cells. J Cell Biochem. 116:2127–2138. 2015.PubMed/NCBI View Article : Google Scholar
31	Zhao R, Zhu Y and Sun B: Exploration of the Effect of mmu-miR-142-5p on Osteoblast and the Mechanism. Cell Biochem Biophys. 71:255–260. 2015.PubMed/NCBI View Article : Google Scholar
32	Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ and Rosen V: BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet. 38(1424)2006.PubMed/NCBI View Article : Google Scholar
33	Singh JA, Schelck C, Harmsen S and Lewallen D: AB0757 Clinically important improvement thresholds for Harris hip score and its ability to predict revision risk after primary total hip arthroplasty. BMC Musculoskelet Disord. 17(256)2016.PubMed/NCBI View Article : Google Scholar
34	Higgins BT, Barlow DR, Heagerty NE and Lin TJ: Anterior vs. posterior approach for total hip arthroplasty, a systematic review and meta-analysis. J Arthroplasty. 30:419–434. 2015.PubMed/NCBI View Article : Google Scholar
35	de Amorim FP, Ornelas SS, Diniz SF, Batista AC and da Silva TA: Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats. J Mol Histol. 39(401)2008.PubMed/NCBI View Article : Google Scholar
36	Wang XF, Zhang YK, Yu ZS and Zhou JL: The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients. Mol Med Rep. 7:1169–1172. 2013.PubMed/NCBI View Article : Google Scholar